EU backs development of molecular Dx test for malaria

09/25/2013 | GenomeWeb Daily News (free registration)

Forsite Diagnostics will use a $728,438 grant from the European Commission to support the development of a molecular test to diagnose malaria quickly. The company is developing the blood-based assay for use in detecting Plasmodium falciparum or Plasmodium vivaxis parasites, which trigger malaria, to help doctors prescribe appropriate treatments immediately.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC